Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. March 13, 2019. Alex Azar.

Executive Summary

Norman "Ned" Sharpless, director of the National Cancer Institute, will lead US FDA as its acting commissioner when agency head Scott Gottlieb steps down next month. See what Health and Human Services Secretary Alex Azar said about the appointment here.

"In a move to put into place a new Commissioner of Food and Drugs as soon as possible, I am pleased to announce that the current director of the National Cancer Institute, Dr. Norman 'Ned' Sharpless, will serve as Acting Commissioner of Food and Drugs, upon the conclusion of Commissioner [Scott] Gottlieb’s incredibly successful tenure, ending in mid-April." –Alex Azar, secretary, US Health and Human Services

Click here for a free trial of Medtech Insight

 
Advertisement

Related Content

NCI Director And Former Dx Start-Up Founder Sharpless Will Helm FDA

Topics

Advertisement
UsernamePublicRestriction

Register

MT124777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel